A well-established use for next-generation sequencing is identifying people with early-stage hereditary cancers. It doesn’t make sense for Medicare to block their access to this test.
A well-established use for next-generation sequencing is identifying people with early-stage hereditary cancers. It doesn’t make sense for Medicare to block their access to this test.
Copyright © 2021 | MH Magazine WordPress Theme by MH Themes